cemiplimab
R2810-ONC-1540
Phase 2 small_molecule completed
Quick answer
cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Advanced Cutaneous Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed